« Projekte
Multicenter, double blind, placebo controlled, randomized, phase III study of tifacogin (Recombinant Tissue Pathway Inhibitor (rTFPI/SC-59735) in severe sepsis
Finanzierung:
Industrie;
Prof. Radke: Multicenter, double blind, placebo controlled, randomized, phase III study of tifacogin (Recombinant Tissue Pathway Inhibitor (rTFPI/SC-59735) in severe sepsis
Kontakt

weitere Projekte

Die Daten werden geladen ...